Article Information
History
- February 2, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- MI Oliveira da Silva1,2,
- M Santejo1,
- IW Babcock3,
- A Magalhães4,
- LS Minamide3,
- E Castillo5,
- E Gerhardt6,
- C Fahlbusch6,
- RA Swanson5,
- TF Outeiro6,7,8,9,10,
- JR Bamburg3 and
- MA Liz1,*
- 1Neurodegeneration Team, Nerve Regeneration Group, IBMC – Instituto de Biologia Molecular e Celular, Universidade do Porto, Portugal, and i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal
- 2ICBAS – Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
- 3Department of Biochemistry and Molecular Biology, Colorado State University, CO, USA
- 4Addiction Biology Group, IBMC – Instituto de Biologia Molecular e Celular, Universidade do Porto, Portugal, and i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal
- 5Department of Neurology, University of California, San Francisco, CA, USA
- 6Department of Experimental Neurodegeneration, University Medical Center Göttingen, Göttingen, Germany
- 7Cluster of Excellence “Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells” (MBExC), University of Göttingen, Germany
- 8Max Planck Institute for Experimental Medicine, Göttingen, Germany
- 9Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Framlington Place, Newcastle Upon Tyne, NE2 4HH, UK
- 10Scientific employee with a honorary contract at Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Göttingen, Germany
- ↵*Correspondence
: Márcia A Liz. e-mail: maliz{at}ibmc.up.pt